Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Emulate has raised $47.1M in total funding. The most recent round was Series F. The last funding was announced in March 2024.
Emulate's investors include Alumni Ventures, Founders Fund, Qiming Venture Partners, Perceptive Advisors, Starlight Ventures.
Emulate is headquartered in Boston, United States.
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Emulate is at the Series F stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Emulate — Funding & Investors." VCBacked, March 20, 2024, https://www.vcbacked.co/company/emulate. Accessed September 29, 2026.
VCBacked. (2024). Emulate — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/emulate
{{cite web |title=Emulate — Funding & Investors |url=https://www.vcbacked.co/company/emulate |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated